688710 益诺思
已收盘 11-20 15:00:00
资讯
新帖
简况
益诺思(688710)11月19日主力资金净卖出1255.58万元
证券之星 · 11-20 08:29
益诺思(688710)11月19日主力资金净卖出1255.58万元
股市必读:益诺思新发布《关于公司通过美国FDA现场检查的公告》
证券之星 · 11-20 01:20
股市必读:益诺思新发布《关于公司通过美国FDA现场检查的公告》
益诺思最新公告:通过美国FDA现场检查
证券之星 · 11-19 18:10
益诺思最新公告:通过美国FDA现场检查
11月19日益诺思跌5.35%,汇添富医药保健混合A基金重仓该股
证券之星 · 11-19 16:45
11月19日益诺思跌5.35%,汇添富医药保健混合A基金重仓该股
益诺思(688710)11月18日主力资金净卖出1759.93万元
证券之星 · 11-19 08:25
益诺思(688710)11月18日主力资金净卖出1759.93万元
11月18日益诺思跌9.50%,汇添富医药保健混合A基金重仓该股
证券之星 · 11-18 16:44
11月18日益诺思跌9.50%,汇添富医药保健混合A基金重仓该股
益诺思(688710)11月13日主力资金净卖出1029.52万元
证券之星 · 11-14
益诺思(688710)11月13日主力资金净卖出1029.52万元
益诺思董事长常艳:中国创新药资产价值持续增厚,未来两三年AI应用有望出现规模化变化
长三角资本局 · 11-13
益诺思董事长常艳:中国创新药资产价值持续增厚,未来两三年AI应用有望出现规模化变化
11月13日益诺思跌7.28%,汇添富医药保健混合A基金重仓该股
证券之星 · 11-13
11月13日益诺思跌7.28%,汇添富医药保健混合A基金重仓该股
益诺思(688710)11月9日主力资金净买入1520.61万元
证券之星 · 11-10
益诺思(688710)11月9日主力资金净买入1520.61万元
益诺思(688710)11月6日主力资金净卖出872.15万元
证券之星 · 11-07
益诺思(688710)11月6日主力资金净卖出872.15万元
11月6日益诺思跌6.52%,汇添富医药保健混合A基金重仓该股
证券之星 · 11-06
11月6日益诺思跌6.52%,汇添富医药保健混合A基金重仓该股
益诺思(688710)11月5日主力资金净卖出3217.97万元
证券之星 · 11-06
益诺思(688710)11月5日主力资金净卖出3217.97万元
11月4日益诺思涨17.06%,汇添富医药保健混合A基金重仓该股
证券之星 · 11-04
11月4日益诺思涨17.06%,汇添富医药保健混合A基金重仓该股
益诺思(688710)11月3日主力资金净卖出2039.69万元
证券之星 · 11-04
益诺思(688710)11月3日主力资金净卖出2039.69万元
11月3日益诺思跌11.01%,汇添富医药保健混合A基金重仓该股
证券之星 · 11-03
11月3日益诺思跌11.01%,汇添富医药保健混合A基金重仓该股
益诺思(688710)11月2日主力资金净买入192.34万元
证券之星 · 11-03
益诺思(688710)11月2日主力资金净买入192.34万元
股市必读:益诺思新发布《关于以公开摘牌方式收购上海益临思医药开发有限公司79.9015%股权暨关联交易的公告》
证券之星 · 11-02
股市必读:益诺思新发布《关于以公开摘牌方式收购上海益临思医药开发有限公司79.9015%股权暨关联交易的公告》
益诺思(688710)披露以公开摘牌方式收购益临思79.9015%股权暨关联交易公告,10月30日股价上涨8.08%
证券之星 · 10-30
益诺思(688710)披露以公开摘牌方式收购益临思79.9015%股权暨关联交易公告,10月30日股价上涨8.08%
益诺思(688710)2026年三季报简析:营收净利润同比双双增长,存货明显上升
证券之星 · 10-28
益诺思(688710)2026年三季报简析:营收净利润同比双双增长,存货明显上升
加载更多
公司概况
公司名称:
上海益诺思生物技术股份有限公司
所属行业:
研究和试验发展
上市日期:
2024-09-03
主营业务:
上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是生物医药早期成药性评价、非临床研究、临床检测及转化研究。
发行价格:
19.06
{"stockData":{"symbol":"688710","market":"SH","secType":"STK","nameCN":"益诺思","latestPrice":70,"timestamp":1795158000000,"preClose":71.8,"halted":0,"volume":3443293,"delay":0,"changeRate":-0.0251,"floatShares":92456200,"shares":141000000,"eps":0.5553,"marketStatus":"已收盘","change":-1.8,"latestTime":"11-20 15:00:00","open":70.5,"high":73.85,"low":69.19,"amount":247000000,"amplitude":0.0649,"askPrice":70,"askSize":2,"bidPrice":69.99,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.5553,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":71.8,"symbolType":"stock_kcb","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":78.98,"lowLimit":64.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":140979615,"isCdr":false,"pbRate":4.07,"roa":"--","peRate":126.057987,"roe":"3.96%","epsLYR":-0.22,"committee":0.758794,"marketValue":9869000000,"turnoverRate":0.0372,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-23。","afterMarket":{"amount":0,"volume":0,"close":70,"buyVolume":0,"sellVolume":0,"time":1795160037746,"indexStatus":"已收盘 11-20 15:30:00","preClose":71.8},"floatMarketCap":6472000000},"requestUrl":"/m/hq/s/688710","defaultTab":"news","newsList":[{"id":"2684718507","title":"益诺思(688710)11月19日主力资金净卖出1255.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684718507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684718507?lang=zh_cn&edition=full","pubTime":"2026-11-20 08:29","pubTimestamp":1795134559,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月19日收盘,益诺思报收于71.8元,下跌5.35%,换手率3.57%,成交量3.3万手,成交额2.41亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入1572.12万元,融资偿还1579.97万元,融资净偿还7.85万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112000006705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684068179","title":"股市必读:益诺思新发布《关于公司通过美国FDA现场检查的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2684068179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684068179?lang=zh_cn&edition=full","pubTime":"2026-11-20 01:20","pubTimestamp":1795108826,"startTime":"0","endTime":"0","summary":"公司公告汇总关于公司通过美国FDA现场检查的公告上海益诺思生物技术股份有限公司于2026年接受了美国食品药品监督管理局的良好实验室规范全面现场检查,检查范围包括组织机构及人员、设施设备、质量保证体系、计算机化系统管理、试验操作及管理等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112000000647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684492717","title":"益诺思最新公告:通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2684492717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684492717?lang=zh_cn&edition=full","pubTime":"2026-11-19 18:10","pubTimestamp":1795083031,"startTime":"0","endTime":"0","summary":"益诺思(688710.SH)公告称,公司于2026年度内接受美国FDA的GLP全面现场检查,近日收到FDA签发的现场检查报告,确认公司符合FDA良好实验室规范规定,顺利通过本次检查,检查结果为自愿行动。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900032652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684929088","title":"11月19日益诺思跌5.35%,汇添富医药保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684929088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684929088?lang=zh_cn&edition=full","pubTime":"2026-11-19 16:45","pubTimestamp":1795077937,"startTime":"0","endTime":"0","summary":"证券之星消息,11月19日益诺思跌5.35%创60日新低,收盘报71.8元,换手率3.57%,成交量3.3万手,成交额2.41亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共72家,其中持有数量最多的公募基金为汇添富基金的汇添富医药保健混合A。汇添富医药保健混合A目前规模为26.03亿元,最新净值2.152,较上一交易日下跌1.65%,近一年上涨7.71%。汇添富医药保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900029973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684259910","title":"益诺思(688710)11月18日主力资金净卖出1759.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684259910","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684259910?lang=zh_cn&edition=full","pubTime":"2026-11-19 08:25","pubTimestamp":1795047921,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月18日收盘,益诺思报收于75.86元,下跌9.5%,换手率4.55%,成交量4.21万手,成交额3.23亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入2390.18万元,融资偿还1453.96万元,融资净买入936.22万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900006999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684480966","title":"11月18日益诺思跌9.50%,汇添富医药保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684480966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684480966?lang=zh_cn&edition=full","pubTime":"2026-11-18 16:44","pubTimestamp":1794991491,"startTime":"0","endTime":"0","summary":"证券之星消息,11月18日益诺思跌9.50%创60日新低,收盘报75.86元,换手率4.55%,成交量4.21万手,成交额3.23亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共72家,其中持有数量最多的公募基金为汇添富基金的汇添富医药保健混合A。汇添富医药保健混合A目前规模为26.03亿元,最新净值2.188,较上一交易日上涨0.09%,近一年上涨9.56%。汇添富医药保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800031948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683681801","title":"益诺思(688710)11月13日主力资金净卖出1029.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683681801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683681801?lang=zh_cn&edition=full","pubTime":"2026-11-14 08:27","pubTimestamp":1794616028,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月13日收盘,益诺思报收于87.09元,下跌7.28%,换手率2.65%,成交量2.45万手,成交额2.2亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入1635.92万元,融资偿还1690.95万元,融资净偿还55.03万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111400007560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683679574","title":"益诺思董事长常艳:中国创新药资产价值持续增厚,未来两三年AI应用有望出现规模化变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2683679574","media":"长三角资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683679574?lang=zh_cn&edition=full","pubTime":"2026-11-13 18:48","pubTimestamp":1794566880,"startTime":"0","endTime":"0","summary":"圆桌讨论上,益诺思董事长、总裁常艳表示,过去半年,中国创新药产业发生的重要变化,不仅是创新药资产数量的持续增长,更在于资产质量与价值的不断提升。常艳表示,这一变化正在推动创新药研发向更加注重临床价值和早期证据的方向发展,也将成为中国创新药产业持续输出高质量资产的重要基础。常艳预计,随着前端AI研发与实验验证闭环逐步完善,AI生成分子的效率有望进一步提升,未来两三年,相关应用可能出现更明显的规模化变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/csjzbj/2026-11-13/doc-iniyqwtz3584277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIQ","KURE","688710","BK0216","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683757324","title":"11月13日益诺思跌7.28%,汇添富医药保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683757324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683757324?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:48","pubTimestamp":1794559683,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日益诺思跌7.28%,收盘报87.09元,换手率2.65%,成交量2.45万手,成交额2.2亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共72家,其中持有数量最多的公募基金为汇添富基金的汇添富医药保健混合A。汇添富医药保健混合A目前规模为26.03亿元,最新净值2.271,较上一交易日上涨0.09%,近一年上涨12.7%。汇添富医药保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300030085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682742353","title":"益诺思(688710)11月9日主力资金净买入1520.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682742353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682742353?lang=zh_cn&edition=full","pubTime":"2026-11-10 08:48","pubTimestamp":1794271695,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月9日收盘,益诺思报收于89.53元,上涨4.1%,换手率2.98%,成交量2.75万手,成交额2.45亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入986.22万元,融资偿还1828.23万元,融资净偿还842.01万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000010314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681138508","title":"益诺思(688710)11月6日主力资金净卖出872.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681138508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681138508?lang=zh_cn&edition=full","pubTime":"2026-11-07 09:15","pubTimestamp":1794014107,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月6日收盘,益诺思报收于86.0元,下跌6.52%,换手率3.97%,成交量3.67万手,成交额3.18亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入2646.96万元,融资偿还2186.96万元,融资净买入460.0万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700010166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681519068","title":"11月6日益诺思跌6.52%,汇添富医药保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681519068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681519068?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:38","pubTimestamp":1793957917,"startTime":"0","endTime":"0","summary":"证券之星消息,11月6日益诺思跌6.52%,收盘报86.0元,换手率3.97%,成交量3.67万手,成交额3.18亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共72家,其中持有数量最多的公募基金为汇添富基金的汇添富医药保健混合A。汇添富医药保健混合A目前规模为26.03亿元,最新净值2.342,较上一交易日上涨2.95%,近一年上涨17.69%。汇添富医药保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600029104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681845468","title":"益诺思(688710)11月5日主力资金净卖出3217.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681845468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681845468?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:32","pubTimestamp":1793925172,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月5日收盘,益诺思报收于92.0元,下跌0.54%,换手率5.81%,成交量5.37万手,成交额5.03亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入2955.2万元,融资偿还4172.8万元,融资净偿还1217.6万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680039328","title":"11月4日益诺思涨17.06%,汇添富医药保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680039328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680039328?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:26","pubTimestamp":1793784377,"startTime":"0","endTime":"0","summary":"证券之星消息,11月4日益诺思涨17.06%,收盘报92.5元,换手率5.63%,成交量5.2万手,成交额4.39亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共72家,其中持有数量最多的公募基金为汇添富基金的汇添富医药保健混合A。汇添富医药保健混合A目前规模为26.03亿元,最新净值2.13,较上一交易日下跌2.96%,近一年上涨4.41%。汇添富医药保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400032500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680701737","title":"益诺思(688710)11月3日主力资金净卖出2039.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680701737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680701737?lang=zh_cn&edition=full","pubTime":"2026-11-04 08:46","pubTimestamp":1793753170,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月3日收盘,益诺思报收于79.02元,下跌11.01%,换手率4.08%,成交量3.78万手,成交额3.11亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入2120.49万元,融资偿还2059.52万元,融资净买入60.98万元,连续3日净买入累计1158.4万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400011018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680746655","title":"11月3日益诺思跌11.01%,汇添富医药保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680746655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680746655?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:03","pubTimestamp":1793696605,"startTime":"0","endTime":"0","summary":"证券之星消息,11月3日益诺思跌11.01%,收盘报79.02元,换手率4.08%,成交量3.78万手,成交额3.11亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共72家,其中持有数量最多的公募基金为汇添富基金的汇添富医药保健混合A。汇添富医药保健混合A目前规模为26.03亿元,最新净值2.195,较上一交易日上涨0.69%,近一年上涨7.13%。汇添富医药保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300033730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680792981","title":"益诺思(688710)11月2日主力资金净买入192.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680792981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680792981?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:33","pubTimestamp":1793666024,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月2日收盘,益诺思报收于88.8元,下跌4.74%,换手率5.2%,成交量4.8万手,成交额4.36亿元。近5日资金流向一览见下表:益诺思融资融券信息显示,融资方面,当日融资买入2093.48万元,融资偿还1680.6万元,融资净买入412.89万元。益诺思主营业务:专业提供生物医药非临床研究服务为主的综合研发服务企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680202174","title":"股市必读:益诺思新发布《关于以公开摘牌方式收购上海益临思医药开发有限公司79.9015%股权暨关联交易的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680202174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680202174?lang=zh_cn&edition=full","pubTime":"2026-11-02 01:16","pubTimestamp":1793553374,"startTime":"0","endTime":"0","summary":"公司公告汇总:益诺思以5436.23万元公开摘牌收购益临思79.9015%股权,交易完成后标的公司将纳入合并报表范围。交易不构成重大资产重组,且因采用公开摘牌方式,可免于按照关联交易方式审议和披露。国泰海通证券股份有限公司关于上海益诺思生物技术股份有限公司以公开摘牌方式收购上海益临思医药开发有限公司79.9015%股权暨关联交易的核查意见益诺思拟以公开摘牌方式收购上海益临思医药开发有限公司79.9015%股权,交易价格为54,362,343.85元,资金来源为自有资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0216","159938","09939","BK1574","688710","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679215975","title":"益诺思(688710)披露以公开摘牌方式收购益临思79.9015%股权暨关联交易公告,10月30日股价上涨8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679215975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679215975?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:37","pubTimestamp":1793360267,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,益诺思报收于93.22元,较前一交易日上涨8.08%,最新总市值为131.42亿元。公司于近日披露《关于以公开摘牌方式收购上海益临思医药开发有限公司79.9015%股权暨关联交易的公告》。公告显示,上海益诺思生物技术股份有限公司通过公开摘牌方式收购中国医药工业研究总院有限公司持有的上海益临思医药开发有限公司79.9015%股权,交易价格为54,362,343.85元,资金来源为自有资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000048297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678467732","title":"益诺思(688710)2026年三季报简析:营收净利润同比双双增长,存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2678467732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678467732?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:18","pubTimestamp":1793189900,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期益诺思发布2026年三季报。截至本报告期末,公司营业总收入7.86亿元,同比上升37.8%,归母净利润9401.37万元,同比上升735.74%。本报告期益诺思存货明显上升,存货同比增幅达50.82%。持有益诺思最多的基金为汇添富医药保健混合A,目前规模为26.03亿元,最新净值2.112,较上一交易日下跌3.61%,近一年上涨3.48%。本文数据来源于益诺思2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800046973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795207682568,"stockEarnings":[{"period":"1week","weight":-0.1962},{"period":"1month","weight":-0.1723},{"period":"3month","weight":-0.2651},{"period":"6month","weight":0.0799},{"period":"1year","weight":0.508},{"period":"ytd","weight":0.5855}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海益诺思生物技术股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"7428人(较上一季度增加39.94%)","perCapita":"12446股","listingDate":"2024-09-03","address":"上海市浦东新区中国(上海)自由贸易试验区郭守敬路199号106室","registeredCapital":"14097万元","survey":" 上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是生物医药早期成药性评价、非临床研究、临床检测及转化研究。","listedPrice":19.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益诺思,688710,益诺思股票,益诺思股票老虎,益诺思股票老虎国际,益诺思行情,益诺思股票行情,益诺思股价,益诺思股市,益诺思股票价格,益诺思股票交易,益诺思股票购买,益诺思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}